New appointment at AAIPharma Services
This article was originally published in Scrip
AAIPharma Services (US) has appointed Christopher Smith vice-president of quality and regulatory affairs. The appointment is AAI Pharma's first since its pharmaceutical development division was bought by the private equity firm Water Street Healthcare Partners last month (scripnews.com, July 21st, 2009). Mr Smith has more than 30 years' experience in the pharmaceutical industry, having worked for the US FDA, Abbott Laboratories and Endeavor Pharmaceuticals.